Back to catalogue
№ 212 30 filings · 2021-08-05 → 2026-07-07

INVESTEC PLC

INVP
Banks Share price 663p Market cap £4.2bn Overall fit 320 /1000

Quality mid-cap specialist bank at a fair (not cheap) valuation, but almost no direct AI-receiver exposure and only moderate operating leverage — misses the primary pillar of the investor mandate despite acceptable downside protection.

Fair value range 650p–770p Mid case · £4.5bn
Absolute upside +7.1% vs current market cap
Conviction 4/5 confidence in fair call
Supports the call
  • Clean IFRS disclosure with tight medium-term targets
  • Multiple valuation approaches converge (P/TNAV 1.2-1.35x, P/E 8.5-10x)
  • Consistent delivery vs. pre-close guidance
Limits the call
  • UK credit loss ratio persistently at upper end of TTC range
  • Undisclosed German cum-ex investigation tail risk
Methodology

Blended P/TNAV (1.20-1.35x) with forward P/E cross-check

In one line · bull case

Well-managed mid-teens ROTE specialist bank + wealth manager trading at ~1.17x TNAV with a 6% yield and visible medium-term earnings inflection.

In one line · biggest risk

UK asset quality deterioration or an adverse German cum-ex resolution could compress both earnings and multiple simultaneously.

Drivers
AI beneficiary 15 /100
Pure bank/wealth manager — spends on tech modernisation but captures no AI value chain economics.
Operating leverage 45 /100
Moderate; guidance flags FY27 as peak investment year with jaws expected to turn positive from FY28.
Earnings vs expectations 70 /100
Consistent meet-to-modest-beat vs. their own tight pre-close guidance across FY24-FY26.
Growth momentum 55 /100
Mid-single-digit adjusted EPS growth; FY27 guided flattish (13-14% ROE); acceleration expected FY28+.
Moat 50 /100
Franchise and integrated 'One Investec' model are real but narrow; execution-driven rather than structural.
Earnings quality 72 /100
Adjusted vs. basic reconciles cleanly; strategic actions disclosed; Rathbones equity-accounting is transparent.
Management quality 72 /100
Long-tenured CEO, disciplined capital returns (Ninety One demerger, buybacks), credible medium-term targets.
Cyclicality 60 /100
Bank with EM exposure and rate-sensitive NII; credit cycle exposure typical of specialist lenders.
Leverage 75 /100
Bank balance sheet; CET1 13.0-13.6% is sound but leverage inherent to model.
Value-trap signals · 3
  • UK credit loss ratio elevated at 57bps vs. TTC upper bound
  • Undisclosed German cum-ex investigation exposure
  • Basel output floor phasing in through 2028

Investec PLC (INVP) — Investment Research Note

Executive summary

Investec is a dual-listed specialist bank and wealth manager operating in the UK and Southern Africa, offering private banking, corporate & investment banking, and discretionary wealth management (the latter now delivered via its 43.15% associate stake in Rathbones). Over FY2022-FY2026, adjusted EPS compounded from 55.1p to 82.9p as the group executed a post-CMD (2019) simplification, benefited from the interest rate cycle, and returned c.£1.6bn+ to shareholders through the Ninety One distribution and share buy-backs. The single most important point for valuation is that the shares trade at ~1.17x TNAV for a group delivering 15.7% ROTE with an intact 13-17% ROE target range through FY2030 — a fair-to-cheap rating, not a demanding one.

Fair value estimate

  • Methodology: blended P/TNAV (primary — anchored on a 15.7% ROTE vs. ~10-11% cost of equity) and forward P/E cross-check.
  • P/TNAV: TNAV 553.1p × 1.20-1.35x (justified premium for mid-teens ROTE, decent capital) = 664-747p.
  • Forward P/E: FY27 guidance implies broadly flat-to-modest EPS growth (peak investment year); apply 8.5-10x to FY26 adjusted EPS of 82.9p = 705-829p.
  • Fair value range: 650p – 770p per share, mid ≈ 710p.
  • Implied market cap range: £4,085m – £4,839m (mid ~£4,463m) vs. current £4,167m.
  • Absolute upside/downside: mid-case upside ≈ +10% (range: +0.8% to +19.4%). Add ~6% dividend yield for total return.

Sector context

  • Sector confirmed: Financials / Banks (mid-cap specialist bank & wealth manager).
  • Profile vs. peers: quality above typical UK domestic banks — cost/income of 52.9% is broadly in line, but ROE/ROTE (13.6%/15.7%) sits above most UK domestic peers and is achieved with strong capital (CET1 13-13.6%) and LCR of 349% (plc). Growth (~4-6% EPS) is modest; leverage is inherent to banking. Wealth associate (Rathbones) is a differentiator.
  • Comparable peers: Standard Chartered (also EM-tilted), Close Brothers (UK specialist banking), Rathbones/St James's Place (wealth); Julius Baer for the private-banking angle.

Investment thesis (3 bullets)

  • Well-executed strategy with visible ROE trajectory: Group is on track to reach the upper end of a 13-17% ROE target range by FY2030, with Southern Africa targeting 18-20% and UK ROTE guided to 13-17%. Peak investment year is FY2027, with earnings inflection from FY2028 2026-05 final results.
  • Attractive shareholder returns: 46.4% payout, £110m/R2.5bn buyback completed in FY26 alongside the earlier £245m programme, and dividend up 5.5% to 38.5p implying a ~6% yield at 645p. Rathbones stake and Ninety One distribution demonstrate active capital management 2026-05 final results; 2024-11 half-year.
  • Rathbones optionality: 43.15% stake in the UK's leading discretionary wealth manager (£113.6bn FUMA), delivering £76m annualised synergies (well ahead of £60m target), and being repositioned to an integrated assets-under-advice model. Provides capital-light earnings growth via the associate line 2026-05 final results.

Key risks (3 bullets)

  • Rate/endowment reversal in progress: NII declined 1.6% in FY26 on lower average rates and margin compression; further rate cuts would continue to erode the recent tailwind. Southern Africa CLR could migrate up from a benign 14bps 2026-05 final results.
  • UK asset quality is running elevated: UK CLR of 57-60bps sits at the upper end of its through-the-cycle range, Stage 3 exposures at 3.4% of gross core loans, and the FCA motor finance provision (£30m) remains materially uncertain pending legal challenge to the redress scheme 2026-05 final results.
  • Cum-ex tax arbitrage overhang and SA macro/FX: German cum-ex investigations at Investec Bank plc remain unresolved with potential legal, financial and reputational consequences (Group has explicitly avoided disclosing detail to avoid prejudicing outcome). Rand translation continues to swing reported vs. neutral currency growth 2026-05 final results.

Operating leverage

Investec has moderate operating leverage typical of a scaled bank+wealth combination. FY26 revenue grew 4.2% (£90.9m) while operating costs grew 4.7% (£53.9m), producing a mildly negative jaws ratio and a slightly worse cost/income (52.9% vs. 52.6%) — the group is actively spending on Corporate mid-market build-out and Private Client platforms, so incremental revenue is currently absorbing incremental cost. Guidance flags FY27 as "peak investment year" with positive inflection from FY28, implying visible operating leverage is 12-18 months out. Fixed costs (personnel + technology + regulatory) dominate; variable comp scales with performance. A 10-20% revenue upside would probably produce ~15-30% operating profit uplift — not the multiple-of-profit dynamic the investor seeks. Wealth & Investment adjusted operating profit +13.9% on 12.7% revenue growth shows the cleanest leverage within the group 2026-05 final results, FY2025 & FY2026 income statements.

Value-trap signals

  • Elevated UK credit loss ratio (57bps) versus SA (14bps), driven by concentrated Stage 3 exposures — not deteriorating trend but sitting persistently above TTC range.
  • Basel output floor introduction reduced Investec Limited CET1 by 40bps (65% phased in; full 72.5% by 2028) — a slow structural capital drag.
  • Historical German cum-ex investigation with undisclosed provision size.
  • FCA motor finance scheme still under legal challenge.
  • Otherwise, the discount to typical mid-teens ROTE bank multiples reflects UK asset-quality concerns and SA/EM overhang, not fundamental deterioration.

Earnings vs. expectations

Investec has an unusually disciplined pre-close trading update cadence with narrow EPS ranges. In each of the last four reporting periods examined, actual results landed at or near the top of the pre-close range: FY26 adjusted EPS 82.9p vs. March pre-close range 81.6-84.0p (in range); 1H26 40.5p vs. September pre-close 38.7-41.5p; FY25 79.1p vs. March 75-81.2p; 1H24 upgraded from 35.5-37.5p to 38.0-39.0p in November 2023 and delivered 38.7p. The pattern is consistent meet-to-modest-beat versus their own tight guidance, with limited street analyst references but effectively meeting bank consensus. Management is credible and rarely surprises negatively.

Conviction

Conviction: 4 (high)

Anchors: (i) audited, IFRS-compliant, dual-listed disclosure with detailed segmental, capital and credit metrics; (ii) tight, medium-term financial targets (ROE/ROTE/cost-income) provide anchor points; (iii) multiple valuation methods (P/TNAV, P/E, dividend yield) converge on a similar range.

Limits: (i) UK credit trajectory in a persistently weaker macro; (ii) cum-ex overhang has unknown tail risk; (iii) Rathbones associate accounting introduces valuation complexity.

Driver scoring rationale

This is a bank/wealth manager with limited direct AI exposure — a poor fit for the AI-receiver mandate despite being fundamentally decent. Valuation is fair, quality is above average for the sector, but the strategic thesis doesn't align.

Filings consulted · 45

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-07-07Directorate Change And Supplementary Notice OF Agm2026-07-07_9656631_directorate-change-and-supplementary-notice-of-agm.md0.30
  2. 2026-06-23Investec Group 039 S 2026 Annual Report And Agm Notice2026-06-23_9632509_investec-group-039-s-2026-annual-report-and-agm-notice.md0.95
  3. 2026-05-21Final Results 31 03 20262026-05-21_9578809_final-results-31-03-2026.md1.00
  4. 2026-04-10Investec Plc Acquisition OF Shares BY Allan Gray2026-04-10_9515442_investec-plc-acquisition-of-shares-by-allan-gray.md0.75
  5. 2026-03-19Fy26 Pre Close Trading Update2026-03-19_9481350_fy26-pre-close-trading-update.md0.85
  6. 2026-02-04Investec Ltd Share Acquisition BY Standard Bank2026-02-04_9408654_investec-ltd-share-acquisition-by-standard-bank.md0.64
  7. 2025-11-28Half Year Financial Report2025-11-28_9264038_half-year-financial-report.md0.77
  8. 2025-11-20Half Year Financial Report 30 Sep 20252025-11-20_9245448_half-year-financial-report-30-sep-2025.md0.77
  9. 2025-09-19Pre Close Trading Statement2025-09-19_9117856_pre-close-trading-statement.md0.72
  10. 2025-08-07Result OF Agm2025-08-07_9035899_result-of-agm.md0.20
  11. 2025-06-30Notice OF Agm Annual Report Board Change2025-06-30_8954371_notice-of-agm-annual-report-board-change.md0.62
  12. 2025-05-22Final Results Fy31 03 252025-05-22_8891228_final-results-fy31-03-25.md0.65
  13. 2025-03-20Pre Close Trading Statement2025-03-20_8788000_pre-close-trading-statement.md0.55
  14. 2024-11-29Half Year Report2024-11-29_8581239_half-year-report.md0.58
  15. 2024-11-21Half Year Results TO 30 September2024-11-21_8563167_half-year-results-to-30-september.md0.58
  16. 2024-11-08Dividend Declaration2024-11-08_8539325_dividend-declaration.md0.20
  17. 2024-09-20Trading Statement Pre Close 1h20252024-09-20_8427449_trading-statement-pre-close-1h2025.md0.55
  18. 2024-08-08Result OF Agm2024-08-08_8357703_result-of-agm.md0.14
  19. 2024-06-28Notice OF Agm Annual Report And Change Statement2024-06-28_8283528_notice-of-agm-annual-report-and-change-statement.md0.43
  20. 2024-05-23Final Results Fy242024-05-23_8215964_final-results-fy24.md0.45
  21. 2024-03-20Trading Statement2024-03-20_8096474_trading-statement.md0.38
  22. 2024-02-02Agm Statement2024-02-02_8020443_agm-statement.md0.18
  23. 2023-11-22Half Year Report2023-11-22_7897021_half-year-report.md0.41
  24. 2023-11-16Half Year Report2023-11-16_7884409_half-year-report.md0.41
  25. 2023-11-14Dividend Declaration2023-11-14_7880760_dividend-declaration.md0.14
  26. 2023-11-14Dividend Declaration2023-11-14_7880758_dividend-declaration.md0.14
  27. 2023-11-14Dividend Declaration2023-11-14_7880759_dividend-declaration.md0.14
  28. 2023-11-08Update ON Pre Close Trading Statement2023-11-08_7866914_update-on-pre-close-trading-statement.md0.38
  29. 2023-09-26Pre Close Trading Statement Correction2023-09-26_7778932_pre-close-trading-statement-correction.md0.38
  30. 2023-09-22Pre Close Trading Statement2023-09-22_7770843_pre-close-trading-statement.md0.38
  31. 2023-08-03Result OF Agm2023-08-03_7674722_result-of-agm.md0.07
  32. 2023-06-30Agm Statement2023-06-30_7604379_agm-statement.md0.10
  33. 2023-05-18Final Results2023-05-18_7531907_final-results.md0.25
  34. 2023-03-16Pre Close Trading Statement2023-03-16_7440291_pre-close-trading-statement.md0.21
  35. 2022-11-23Half Year Report2022-11-23_7176284_half-year-report.md0.23
  36. 2022-11-17Half Year Report2022-11-17_7412017_half-year-report.md0.23
  37. 2022-09-23Pre Close Trading Update2022-09-23_7065464_pre-close-trading-update.md0.21
  38. 2022-08-04Result OF Agm2022-08-04_7010301_result-of-agm.md0.07
  39. 2022-06-30Notice OF Agm And Publication OF Annual Report2022-06-30_7119825_notice-of-agm-and-publication-of-annual-report.md0.24
  40. 2022-05-19Final Results2022-05-19_6933035_final-results.md0.25
  41. 2022-03-18Pre Close Trading Statement2022-03-18_6970343_pre-close-trading-statement.md0.21
  42. 2021-11-19Half Year Report2021-11-19_6835241_half-year-report.md0.23
  43. 2021-11-08Update ON Pre Close Trading Statement2021-11-08_6686327_update-on-pre-close-trading-statement.md0.21
  44. 2021-09-23Pre Close Trading Statement2021-09-23_6557453_pre-close-trading-statement.md0.21
  45. 2021-08-05Result OF Agm2021-08-05_6440170_result-of-agm.md0.03

This research note was authored by a large language model after reading 30 regulatory filings published between 2021-08-05 and 2026-07-07. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.